BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10884376)

  • 1. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.
    Hahn H; Wojnowski L; Specht K; Kappler R; Calzada-Wack J; Potter D; Zimmer A; Müller U; Samson E; Quintanilla-Martinez L; Zimmer A
    J Biol Chem; 2000 Sep; 275(37):28341-4. PubMed ID: 10884376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unbalanced overexpression of the mutant allele in murine Patched mutants.
    Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H
    Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
    Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
    Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.
    Ecke I; Petry F; Rosenberger A; Tauber S; Mönkemeyer S; Hess I; Dullin C; Kimmina S; Pirngruber J; Johnsen SA; Uhmann A; Nitzki F; Wojnowski L; Schulz-Schaeffer W; Witt O; Hahn H
    Cancer Res; 2009 Feb; 69(3):887-95. PubMed ID: 19155313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice.
    Corcoran RB; Bachar Raveh T; Barakat MT; Lee EY; Scott MP
    Cancer Res; 2008 Nov; 68(21):8788-95. PubMed ID: 18974121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the PTCH coding region in human rhabdomyosarcoma.
    Calzada-Wack J; Schnitzbauer U; Walch A; Wurster KH; Kappler R; Nathrath M; Hahn H
    Hum Mutat; 2002 Sep; 20(3):233-4. PubMed ID: 12204003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
    Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
    Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
    Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
    Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog-independent overexpression of transforming growth factor-beta1 in rhabdomyosarcoma of Patched1 mutant mice.
    Eichenmüller M; Bauer R; Von Schweinitz D; Hahn H; Kappler R
    Int J Oncol; 2007 Aug; 31(2):405-12. PubMed ID: 17611698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice.
    Pazzaglia S; Tanori M; Mancuso M; Rebessi S; Leonardi S; Di Majo V; Covelli V; Atkinson MJ; Hahn H; Saran A
    Oncogene; 2006 Feb; 25(8):1165-73. PubMed ID: 16407852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
    Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
    Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice.
    Zurawel RH; Allen C; Wechsler-Reya R; Scott MP; Raffel C
    Genes Chromosomes Cancer; 2000 May; 28(1):77-81. PubMed ID: 10738305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma.
    Zhan S; Shapiro DN; Helman LJ
    J Clin Invest; 1994 Jul; 94(1):445-8. PubMed ID: 8040287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice.
    Kim JY; Nelson AL; Algon SA; Graves O; Sturla LM; Goumnerova LC; Rowitch DH; Segal RA; Pomeroy SL
    Dev Biol; 2003 Nov; 263(1):50-66. PubMed ID: 14568546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched.
    Wetmore C; Eberhart DE; Curran T
    Cancer Res; 2000 Apr; 60(8):2239-46. PubMed ID: 10786690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a neuronal transcription factor network involved in medulloblastoma development.
    Lastowska M; Al-Afghani H; Al-Balool HH; Sheth H; Mercer E; Coxhead JM; Redfern CP; Peters H; Burt AD; Santibanez-Koref M; Bacon CM; Chesler L; Rust AG; Adams DJ; Williamson D; Clifford SC; Jackson MS
    Acta Neuropathol Commun; 2013 Jul; 1():35. PubMed ID: 24252690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome.
    Hahn H; Wojnowski L; Zimmer AM; Hall J; Miller G; Zimmer A
    Nat Med; 1998 May; 4(5):619-22. PubMed ID: 9585239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model for medulloblastoma and basal cell nevus syndrome.
    Corcoran RB; Scott MP
    J Neurooncol; 2001 Jul; 53(3):307-18. PubMed ID: 11718263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts.
    Zibat A; Uhmann A; Nitzki F; Wijgerde M; Frommhold A; Heller T; Armstrong V; Wojnowski L; Quintanilla-Martinez L; Reifenberger J; Schulz-Schaeffer W; Hahn H
    Carcinogenesis; 2009 Jun; 30(6):918-26. PubMed ID: 19321799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.
    Wetmore C; Eberhart DE; Curran T
    Cancer Res; 2001 Jan; 61(2):513-6. PubMed ID: 11212243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.